EQT Nexus Asia launch puts Asia Pacific private markets in focus
EQT (OM:EQT) has launched EQT Nexus Asia, an evergreen product that pools investor capital into its Asia Pacific private equity platform, providing exposure to healthcare, services, technology and industrial technology across multiple regional markets.
EQT shares trade at SEK318.5, with a 90 day share price return of 11.52% but a year to date share price decline of 11.08%, while total shareholder return is down 1.33% over one year and up 53.42% over three years.
Momentum has softened recently, with a 30 day share price return of 8.40% in decline, even as the launch of EQT Nexus Asia, interest in Australian clinical trials operator Nucleus Network, and the completed Coller Capital combination keep EQT in focus for investors assessing how new initiatives might reshape risk and growth expectations.
Scan EQT alongside other private equity and alternative asset managers by reviewing the hand picked 617 high quality undiscovered gems that are also leaning into Asia focused opportunities.
Bulls see EQT’s Asia push, its tie-up with Coller and fresh buybacks as support for a richer multiple, while bears point to recent share price weakness and a modest value score. Which case do the numbers lean toward next?
Most Popular Narrative: 18% Undervalued
The most widely followed EQT narrative pegs fair value at about SEK387 per share, comfortably above the last close at SEK318.5. This keeps the valuation debate very much alive for anyone watching Nexus Asia and the Coller EQT scale up.
EQT is positioned to capture substantial long-term growth from the ongoing expansion of private capital allocations by both institutional and private wealth clients globally, secular shifts that are expected to drive significant step-ups in fundraising volumes and recurring management fee revenues over the coming years.
The firm's global diversification, especially its push into fast-growing Asian markets (e.g., India, Japan) and the U.S., positions it to benefit as more capital is funneled into private assets in these regions, supporting sustained AUM growth and higher future earnings.
Want to see what has to happen for that fair value to stack up? The narrative leans on brisk revenue expansion, higher margins and a future earnings multiple that assumes EQT continues to compound fee power. Curious which specific growth and profitability paths underpin that price tag and how much execution room analysts are really giving management?
Result: Fair Value of SEK386.93 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, EQT’s story can change quickly if fundraising momentum stalls, or if integration issues from the Coller EQT combination start to pressure fees and profitability.
Find out about the key risks to this EQT narrative.
Another View on EQT’s Valuation
EQT screens as undervalued on SWS fair value work, yet the current P/E of 32x is higher than the Swedish Capital Markets industry at 17.4x and above the fair ratio of 31.2x. That premium hints at valuation risk if growth or sentiment cools even slightly. Which signal should matter more to you?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed views on EQT so far. If you want to move quickly and ground your stance in hard numbers rather than headlines, start by checking the 4 key rewards.
Looking for more EQT style investment ideas?
If EQT has your attention, do not stop there. Use the same disciplined approach across other opportunities that could sharpen your portfolio and highlight fresh risk reward setups.
- Target potential mispricing by using the 249 high quality undervalued stocks that filters for companies combining solid fundamentals with a share price that lags underlying business strength.
- Build a steadier income stream by scanning the 168 dividend fortresses focused on higher yielding businesses where payouts are supported by real cash flows.
- Dial back portfolio stress and concentrate on resilience through the 309 resilient stocks with low risk scores which focuses on companies with stronger balance sheets and milder volatility profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com